Sutro Biopharma, Inc.
METHODS OF USING ANTI-CD74 ANTIBODIES AND ANTIBODY CONJUGATES IN TREATMENT OF T-CELL LYMPHOMA

Last updated:

Abstract:

Provided herein are antibody conjugates with binding specificity for CD74 and compositions comprising the antibody conjugates, including pharmaceutical compositions, methods of producing the conjugates, and methods of using the conjugates and compositions for therapy involving treatment, amelioration, and/or diagnosis of a T-cell lymphoma.

Status:
Application
Type:

Utility

Filling date:

25 Jul 2018

Issue date:

2 Jul 2020